Background and Format:Pharmaceutical Market Europe (PME) is published by PMGroup Worldwide Ltd monthly and is aimed at decision makers and influencers in the pharmaceutical industry across Europe. Covers news, medicine, biotech breakthroughs, meaningful behaviour change, data protection and appointments. For more information about advertising rates, the team can be reached at sales@pmlive.comCirculation:Source: Publisher

Background and Format: The PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly print title Communique are published by PMGroup. The website provides pharma news, analysis, jobs and events. It also highlights what topics related to the industry are trending. Audience and Readership: Pharmaceutical Market Europe is targeted at healthcare professionals working within the pharmaceutical market. Monthly Unique User figure: Source: Publisher Ad Rates: Advertising information can be found here. Alternatively, contact the sales team on +44 (0)1372 414 200 and sales@pmlive.com Other Information: Visitors to the website can register to receive the PMLive free daily (Mon-Fri) email alerts and/or weekly alerts (on Fridays). The daily alerts are received by 4,000 recipients and the weekly alerts by 5,000 people internationally. Videos: www.pmlive.com/intelligence/video

Impact Factor: 0.224 (2015) Circulation: The Publisher does not disclose the circulation. Distribution: The journal is available through subscription. Affiliations: Pharmaceutical Medicine is an affiliate of the Australasian Drug Information Service (ADIS). It is also published in association with the International Federation of Associations of Pharmaceutical Physicians and affiliated with The Society of Pharmaceutical Medicine. Aims of the journal: Pharmaceutical Medicine is a guide to the multidisciplinary specialty of pharmaceutical medicine, encompassing scientific, medical and related activities in the discovery, development, evaluation, registration and monitoring of medicines, the execution of clinical trials, and the regulatory and ethical requirements pertaining to drug development. Articles are peer-reviewed and cover all aspects of pharmaceutical medicine, from the processes involved in the identification of new active substances, though their development and licensing as medicinal products, to the monitoring of their use in clinical practice. Content: The journal publishes peer-reviewed articles covering all aspects of pharmaceutical medicine, from the processes involved in the identification of new active substances, through their development and licensing as medicinal products, to the monitoring of their use in clinical practice. Readership: The journal is targeted at Pharmaceutical physicians, Clinical trial coordinators, Clinical research physicians and managers, Clinical pharmacologists, Clinical toxicologists, Medical advisors, Physician investigators, Regulatory affairs specialists and Drug safety specialists. Editorial contacts: The majority of articles are derived from a structured program of commissioning, However submitted review articles and letters to the Editor are considered for publication. The Publishing Editor can be contacted at Susan.Pochon@springer.com Manuscript Submission: All manuscripts should be submitted to the journal using the Adis manuscript-tracking system here. Step-by-step instructions are available on the website.

Covers Pharmaceuticals and Pharmaceutic Manufacturers with features on Development and Manufacturing, Packaging and Protection, Quality and Logistics.

Previously called American Pharmaceutical Outsourcing and established in 2000. Examines the relevant issues taking place within the contract manufacturing and packaging arenas of the pharmaceutical and biopharmaceutical industries throughout North America. Provides editorial written for the industry by the industry with editorial support the FDA, pharmaceutical companies and leading consultancies. Pharmaceutical Outsourcing DOES accept bylined articles/submissions. Articles should be submitted via e-mail as a Microsoft Word attachment. Author names, job titles and affiliations must be included. All articles should be submitted to the editor. They should be between 2,000 and 2,500 words and unbiased.

Designed to examine the relevant issues taking place within the contract manufacturing and packaging arenas of the pharmaceutical and biopharmaceutical industries throughout North America. Provides editorial written for the industry by the industry with editorial support the FDA, pharmaceutical companies and leading consultancies.

Circulation: The publisher does not disclose the circulation Frequency: Bi-Monthly Aims of the journal: Pharmaceutical Patent Analyst strives to inform its readers of the content of key patents, whilst also providing commentary on important issues related to patent and intellectual property (IP) law. The journal’s content comprises patent reviews that provide appraisals of selected patents in a chosen area, set within the context of the wider relevant R&D landscape. Articles exploring patenting trends as well as those examining new methodologies for searching the patent literature also feature. Readership: Pharmaceutical Patent Analyst is principally targeted at researchers and scientists who need to remain abreast of developments in the patent literature, while additionally enhancing their understanding of associated IP issues. Tthe journal is also for those outside of the research community, notably IP specialists, legal professionals and technology-transfer officers. Content: Complementing the scientific review content of each issue are news updates, editorials, interviews and hot-topic articles presenting opinion and commentary on pressing IP issues related to the pharmaceutical patent lifecycle or to R&D more broadly. Manuscript Submission: Unsolicited manuscripts are accepted for publication; contact the Commissioning Editor with a brief proposal and article outline. All review articles published in the journals are subject to rigorous peer-review by independent experts in the field. Author guidelines can be viewed at here. Ad Rates: Further information on ad rates can be found here.

Edited for managers of the processing, engineering and production phases of pharmaceutical manufacturing. Features include new product listings, technical developments in processing techniques, packaging innovations and information on pharmaceutical raw materials.

Serves as the official journal of the American Association of Pharmaceutical Scientists and written for its members. Presents papers on innovative research spanning the entire spectrum of science that is the foundation of drug discovery, development, evaluation and regulatory approval. Covers small drug molecules, biotechnology products including genes, peptides, proteins and vaccines and genetically engineered cells. Current emphasis includes, but is not limited to, the following areas of preformulation, drug delivery and targeting, formulation design, engineering, processing, pharmacokinetics, pharmacodynamics, pharmacogenomics, molecular biopharmaceutics and computational biopharmaceutics. This outlet offers RSS (Really Simple Syndication).

Established in 1977 and written for manufacturers and producers of pharmaceuticals and medical devices. Offers practical, hands-on information on all aspects of pharmaceutical research, development, manufacturing and processing including: manufacturing machinery and equipment; recipients, chemicals and raw materials; solid dosage forms; and parenterals. Regular editorial topics are: contract services, drug delivery, IT/automation/21CFR11, manufacturing equipment and supplies, packaging and labeling, FDA/regulatory and compliance, cleanrooms/aseptic processing, analysis and testing, parenterals, solid dosage forms, excipients and biopharmaceutical technology. Departments include: From the Editor, Letters, Current Technical Literature, Information Showcase, What's New, New Products, New Literature, Advertisers, Calendar, Career Opportunities and Classified Directory. Columns include Washington Report and Biotech Trends. Also publishes a Buyer's Guide in July, an Outsourcing Resources Directory in August, a IT Solutions/Automation issue in November, and a Corporate Capabilities issue in December. Accepts bylined articles.